Word: journalizer
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
Your eyes can tell a lot about you, perhaps even your future risk of stroke. A seven-year study of 3,654 adults, published in the journal Neurology, found that people who had retinopathy, or damage in the small blood vessels of the retina, were at least 70% more likely than the rest of us to have a stroke...
...pertussis, or whooping cough, among U.S. teens and adults that could be prevented each year with a booster vaccination. Most children, for whom the long-lasting coughing illness can be fatal, get several pertussis shots by age 6, but immunity wears off. A study in the New England Journal of Medicine says one extra shot for teens and adults would do the trick...
...investigation into the new species’ existence. Morwood collaborated with another professor at the University of New England, Peter Brown, to analyze the fossil findings, a process which they just finished. Lieberman wrote about the discovery and its latest developments in yesterday’s edition of the journal Nature. Further testing will be done to prove that the collection of bones is from a distinct human species, according to Lieberman. These specimens have dispelled several prior conclusions about the ancestors of homo sapiens. Analysis of the Floresian residents revealed that a non-homo sapiens species of human lived...
...pressing a button in response to signals displayed on a computer screen. Patients treated with TMS showed up to a 50 percent improvement in their reaction time, while those patients who received a placebo treatment did not show any significant improvement. Since the publication of his study in the journal Neurology in May, Fregni has tested a longer variation of the procedure on 16 additional patients. “Finding the right dosage for treatment is important,” he said. “The effect of one session is short lasting, we need to find the parameters needed...
...risk of disability. The study is part of a larger research project into hospitals’ performance in quality improvement campaigns for stroke patients, including the American Stroke Association-based “Get With the Guidelines.” It will appear in the November issue of the journal Stroke. The drug in question, tissue plasminogen activator (tPA), is the only clot-dissolving drug approved in the treatment of strokes and can only be used within three hours after symptom onset, according to Eric E. Smith, lead author of the study and assistant neurologist at MGH Stroke Service. Some...